Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
ID: 355907Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCEZID (HHS-CDC-NCEZID)

Award Range

$25K - $1M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and an expected award date of July 1, 2025.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation," aimed at enhancing educational resources for families affected by CJD and related prion diseases. The cooperative agreement seeks to provide timely information to families, public health service providers, and health professionals to improve monitoring and understanding of prion diseases, particularly in light of the ongoing chronic wasting disease (CWD) outbreak among deer and elk. Eligible applicants include states, political subdivisions, and nonprofit entities, with funding ranging from $75,000 to a maximum of $100,000, and an estimated total program funding of $500,000. Interested parties should note that applications must be submitted electronically by March 18, 2025, with awards expected to be announced by September 1, 2025; for further inquiries, contact Tracey Ponder at TPonder@cdc.gov or by phone at 404-639-0953.
    Continuing to Enhance Global Health Security: Sustain Efforts and Strategies to Protect and Improve Public Health Globally
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Continuing to Enhance Global Health Security: Sustain Efforts and Strategies to Protect and Improve Public Health Globally." This cooperative agreement aims to build upon existing global health security initiatives by implementing programs that enhance the prevention, detection, and response to public health threats, particularly in light of lessons learned from the COVID-19 pandemic. The initiative is crucial for improving global health systems and mitigating risks associated with epidemics and biological threats. The estimated total program funding is $75 million, with approximately 10 awards expected, and applications must be submitted electronically by January 3, 2025. For further inquiries, interested applicants can contact Shana Eatman at 770.488.3933 or via email at DGHPNOFOs@cdc.gov.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)." This initiative aims to support investigator-initiated research focused on identifying and evaluating potential risk factors associated with ALS, particularly those related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. The program is significant for advancing understanding of ALS and its risk factors, especially in diverse populations, including racial and ethnic minorities and military veterans. Interested applicants can apply for funding ranging from $0 to $500,000, with an estimated total program funding of $7.5 million available for approximately eight awards. Applications must be submitted electronically by November 4, 2024, and inquiries can be directed to Candis M. Hunter, PhD, MSPH, REHS, at ncipcerpo@cdc.gov.
    Strengthening and Developing of Sustainable Global Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Strengthening and Developing of Sustainable Global Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation." This initiative aims to enhance public health workforce development and strengthen global capacity to prevent, detect, and respond to diseases, particularly in light of recent health crises such as COVID-19 and Ebola. The program emphasizes the importance of collaboration among various public health programs and networks, focusing on the Field Epidemiology Training Programs (FETP) and other workforce development initiatives. The estimated total program funding is $100 million, with three awards expected, and applications must be submitted electronically by January 3, 2025. For further inquiries, interested applicants can contact Shana Eatman at 770.488.3933 or via email at DGHPNOFOs@cdc.gov.
    Medical Monitoring Project
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the Medical Monitoring Project (MMP), aimed at enhancing the understanding of the experiences and needs of adults diagnosed with HIV in the United States. This initiative involves a comprehensive surveillance system that collects clinical and behavioral data through interviews and medical chart abstractions, providing valuable insights for prevention planning, policy-making, and resource advocacy. With an estimated total program funding of $70.5 million and the expectation of awarding 23 cooperative agreements, eligible applicants include state health departments and select local health departments, with applications due by January 31, 2025. For further inquiries, interested parties can contact Jason Craw at (404) 639-6395 or via email at emf4@cdc.gov.
    RFA-GH-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-GH-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with no cost-sharing or matching requirements specified. This discretionary funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available. Interested parties should note that the application deadline is October 13, 2025, and can reach out to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)" through a cooperative agreement. This initiative aims to evaluate the effectiveness of existing Clinical Community Linkage (CCL) and social connectedness programs in reducing disparities related to diabetes risk factors, incidence, and complications, while also assessing the impact of various mechanisms on diabetes outcomes. The program is critical for informing future scaling of effective interventions and understanding the characteristics of successful programs, particularly for populations facing documented disparities. The estimated total program funding is $3,150,000, with an award ceiling of $350,000 and an expected three awards. Interested applicants must submit their proposals electronically by January 6, 2025, and can direct inquiries to Dr. Celeste Sanders at CSanders4@cdc.gov or by phone at 770-488-2536.